Data / Form D filings / Vogenx, Inc.
Vogenx, Inc.: Form D filing
Vogenx, Inc., a pharmaceuticals company in Raleigh, NC, filed a Form D with the SEC in 2026. The latest, on January 7, 2026, reports $750,000 sold of a $5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3901 BARRETT DRIVE SUITE 300, P.O. BOX 19469, Raleigh, NC, 27609
- Phone
- (919) 659-5677
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1903784
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 7 | New notice | $5,000,000 | $750,000 | $4,250,000 | 3 | Dec 10 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Green | Executive Officer, Director | |
| Steven Delmar | Executive Officer, Director | |
| William Wilkison | Executive Officer, Director | |
| Pete Pieraccini | Director | |
| Tim Boris | Director | |
| Richard Gorman | Director |
Every Form D from the week of Jan 5 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vogenx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.